Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sini San Jiajian Granules (四逆散加减颗粒模拟剂) is a traditional Chinese medicine (TCM) formulation based on the classical prescription "Sini San" (四逆散), with modifications ("Jiajian" 加减) to tailor the formula for specific clinical presentations. The original Sini San consists of Bupleurum root (Chai Hu), Licorice root (Gan Cao), Bitter Orange fruit (Zhi Shi), and White Peony root (Bai Shao). The "Jiajian" modification means additional herbs may be included or some ingredients adjusted according to patient needs. This granule formulation is used primarily for conditions associated with liver qi stagnation and spleen deficiency, such as gastrointestinal disorders, mood disturbances like depression or irritability, and certain inflammatory conditions. Mechanistic studies suggest that it may modulate neurotransmitter systems including serotonin pathways, neurotrophic factors like BDNF/TrkB signaling, and regulate the hypothalamic-pituitary-adrenal axis[2][9]. It is typically administered orally as a granule dissolved in water. The product is considered a medical-grade TCM granule preparation requiring physician guidance for use[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sini San Jiajian Granules.